Pharmaceutical - Daiichi Sankyo, GlaxoSmithKline

Filter

Popular Filters

Sales of cancer pain therapies set to grow to $5.2 billion in the G7 by 2021

13-12-2012

Sales of cancer pain therapies will increase to $5.2 billion in 2021 in leading seven markets (the USA,…

AmgenBiotechnologyDaiichi SankyodenosumabGlaxoSmithKlineGlobalMarkets & MarketingOncologyPharmaceuticalRanmarkXgeva

GSK and Daiichi Sankyo set up Japanese vaccines JV

02-03-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) says it has signed an agreement with Japan's third-largest…

Asia-PacificDaiichi SankyoGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalVaccines

Back to top